➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Harvard Business School
Baxter
Boehringer Ingelheim
Moodys

Last Updated: June 21, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Camptothecin


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Camptothecin?

Camptothecin is an investigational drug.

There have been 99 clinical trials for Camptothecin. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 1998.

The most common disease conditions in clinical trials are Lung Neoplasms, Small Cell Lung Carcinoma, and Lymphoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Astex Pharmaceuticals, and University of New Mexico.

Recent Clinical Trials for Camptothecin
TitleSponsorPhase
A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP InhibitorsNational Cancer Institute (NCI)Phase 1/Phase 2
How To Evaluate The Efficiency And Safety Of Neoadjuvant Chemotherapy In Locally Advanced Cancer CervixAssiut UniversityPhase 2
Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy in Advanced or Metastatic Cancers of the Stomach and IntestinesNational Cancer Institute (NCI)Phase 1

See all Camptothecin clinical trials

Clinical Trial Summary for Camptothecin

Top disease conditions for Camptothecin
Top clinical trial sponsors for Camptothecin

See all Camptothecin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Medtronic
Boehringer Ingelheim
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.